OPTIDRAIN
Live / Applied — First extension granted (statement of use) (as of 09 Mar 2026)
What this means for you
Not registered yet, but its 20 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99049685
- Mark type
- Word mark
- Filed
- 20 Feb 2025
- Published for opposition
- 08 Apr 2025
- Attorney of record
- Nichole Hayden
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic pharmaceuticals, namely, eye drops, solutions, gels, and ointments used for the treatment of eye conditions, including dry eyes, allergies, infection, inflammation, redness and corneal swelling.
Owner
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
Prosecution history
- 09 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 1 GRANTED
- 03 Dec 2025 — SOU EXTENSION 1 FILED
- 09 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 16 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 16 Feb 2026 — PETITION TO REVIVE-GRANTED
- 16 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 05 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER